Litcius/Paper detail

Mutually exclusive genetic interactions and gene essentiality shape the genomic landscape of primary melanoma

Sofia Birkeälv, Mark Harland, Larissa Satiko Alcântara Sekimoto Matsuyama, Mamun Rashid, Ishan Mehta, Jonathan P. Laye, Kerstin Haase, Tracey Mell, Vivek Iyer, Carla Daniela Robles‐Espinoza, Ultan McDermott, Peter Van Loo, Marieke L. Kuijjer, Patrícia A. Possik, Silvya Stuchi Maria Engler, D. Timothy Bishop, Julia Newton‐Bishop, David J. Adams

2022The Journal of Pathology15 citationsDOIOpen Access PDF

Abstract

Melanoma is a heterogenous malignancy with an unpredictable clinical course. Most patients who present in the clinic are diagnosed with primary melanoma, yet large-scale sequencing efforts have focused primarily on metastatic disease. In this study we sequence-profiled 524 American Joint Committee on Cancer Stage I-III primary tumours. Our analysis of these data reveals recurrent driver mutations, mutually exclusive genetic interactions, where two genes were never or rarely co-mutated, and an absence of co-occurring genetic events. Further, we intersected copy number calls from our primary melanoma data with whole-genome CRISPR screening data to identify the transcription factor interferon regulatory factor 4 (IRF4) as a melanoma-associated dependency. © 2022 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.

Topics & Concepts

MelanomaIRF4GeneMalignancyGeneticsBiologyDiseaseComputational biologyMedicineTranscription factorInternal medicineMelanoma and MAPK PathwaysCutaneous Melanoma Detection and Managementvaccines and immunoinformatics approaches